A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530
Clinical trial NCT02441283 · COMPLETED
Trial details
- NCT number
- NCT02441283
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-22
- Primary completion
- 2019-10-15
- Enrollment
- 384
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.